Heterodimerization of human apelin and bradykinin 1 receptors: Novel signal transduction characteristics

Cellular Signalling

Volumn 26, Issue 7, 2014, Pages 1549-1559

  Bai, Bo ^a   Liu, Lulu ^a   Zhang, Ning ^a   Wang, Chunmei ^a   Jiang, Yunlu ^a   Chen, Jing ^a,b  

^a JINING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Apelin receptor; Bradykinin 1 receptor; G protein coupled receptors; Heterodimer; Resonance energy transfer

Indexed keywords

APELIN; APELIN 13; APELIN RECEPTOR; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ[1-8]; CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HETERODIMER; PROTEIN KINASE C; UNCLASSIFIED DRUG; APLN PROTEIN, HUMAN; APLNR PROTEIN, HUMAN; BRADYKININ; BRADYKININ, DES-ARG(9)-; CRE RECOMBINASE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INTEGRASE; SIGNAL PEPTIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN HEK293; CONTROLLED STUDY; DIMERIZATION; DRUG DEVELOPMENT; DRUG TARGETING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE SILENCING; HETERODIMERIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CALCIUM SIGNALING; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL LINE; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE;

BRADYKININ; CALCIUM; CALCIUM SIGNALING; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; CELL LINE; CELL PROLIFERATION; ENZYME ACTIVATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTEGRASES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NFATC TRANSCRIPTION FACTORS; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTOR, BRADYKININ B1; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84898606916     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.03.022     Document Type: Article

References (29)

1. Rozenfeld R., Devi L.A. Trends Pharmacol. Sci. 2010, 31(3):124-130.
2. Kenakin T.P. Nat. Rev. Drug Discov. 2009, 8(8):617-626.
3. Ferré S., et al. Nat. Chem. Biol. 2009, 5(3):131-134.
4. Ferré S., et al. Pharmacol. Rev. 2014, 66(2):413-434.
5. Carriba P., et al. Neuropsychopharmacology 2007, 32(11):2249-2259.
6. Rios C., Gomes I., Devi L.A. Br. J. Pharmacol. 2006, 148(4):387-395.
7. Zhu W.Z., et al. Circ. Res. 2005, 97(3):244-251.
8. Rashid A.J., et al. Proc. Natl. Acad. Sci. 2007, 104(2):654-659.
9. Hasbi A., et al. Biochemistry 2007, 46(45):12997-13009.
10. Bai B., et al. Acta Biochim. Biophys. Sin. 2008, 40(4):311-318.
11. Masri B., Knibiehler B., Audigier Y. Cell. Signal. 2005, 17(4):415-426.
12. Zeng X.J., et al. Exp. Cell Res. 2010, 316(11):1773-1783.
13. Xu N., et al. Peptides 2009, 30(6):1153-1157.
14. Prado G.N., et al. J. Cell. Physiol. 2002, 193(3):275-286.
15. Leeb-Lundberg L.F., et al. Pharmacol. Rev. 2005, 57(1):27-77.
16. O'Carroll A.-M., et al. J. Endocrinol. 2013, 219(1):R13-R35.
17. Howl J., Payne S.J. Expert Opin. Ther. Targets 2003, 7(2):277-285.
18. Danilczyk U., Penninger J.M. Circ. Res. 2006, 98(4):463-471.
19. Ciruela F., Vilardaga J.-P., Fernández-Dueñas V. Trends Biotechnol. 2010, 28(8):407-415.
20. Kaczor A., Selent J. Curr. Med. Chem. 2011, 18(30):4606-4634.
21. Lohse M.J., Nuber S., Hoffmann C. Pharmacol. Rev. 2012, 64(2):299-336.
22. Li Y., et al. Cell. Signal. 2012, 24(5):991-1001.
23. Wang C., et al. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 2014, 1843(3):652-663.
24. Hein P., et al. EMBO J. 2005, 24(23):4106-4114.
25. Cheng Z., et al. Curr. Chem. Genomics 2010, 4(1).
26. AbdAlla S., et al. Nat. Med. 2001, 7(9):1003-1009.
27. Chun H.J., et al. J. Clin. Invest. 2008, 118(0xdd949d4>):3343-3354.
28. Tatemoto K., et al. Regul. Pept. 2001, 99(2):87-92.
29. Kuhr F., et al. Neuropeptides 2010, 44(2):145-154.